发明名称 LINGO BINDING MOLECULE AND PHARMACEUTICAL USE THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To provide binding molecules capable of binding to rat, cynomolgus monkey and human LINGO polypeptide, a polynucleotide encoding such binding molecule; an expression vector comprising the polynucleotide; an expression system comprising a polynucleotide capable of producing a binding molecule; an isolated host cell comprising the expression system as defined above; use of such binding molecule as a pharmaceutical, especially in treatment to promote axonal regeneration/plasticity; a pharmaceutical composition comprising the binding molecule; and a method of treatment of diseases associated with axonal degeneration and demyelination. <P>SOLUTION: The binding molecule to a particular region or epitope of LINGO-1 is provided. The binding molecule binds to the mature ectodomain (residues 34-550) of rat LINGO-1, cynomolgus monkey LINGO-1 and human LINGO-1 with a dissociation constant (K<SB POS="POST">D</SB>)<1,000 nM, more preferably with the K<SB POS="POST">D</SB><100 nM, most preferably with the K<SB POS="POST">D</SB><10 nM. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013056888(A) 申请公布日期 2013.03.28
申请号 JP20120222370 申请日期 2012.10.04
申请人 NOVARTIS AG 发明人 WALMSLEY ADRIAN;WISHART WILLIAM LEONARD;CORTES-CROS MARTA;PRASSLER JOSEF;KLAGGE INGO
分类号 C07K16/28;A61K39/395;A61P25/00;C12N15/09 主分类号 C07K16/28
代理机构 代理人
主权项
地址